What is Legacy Technology Holdings, Inc. (LTHO) stock price today?

Legacy Technology Holdings, Inc. (LTHO) is currently trading at $0.00.

What is LTHO P/E ratio?

Legacy Technology Holdings, Inc.'s P/E ratio is -0.18. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is LTHO return on equity (ROE)?

Legacy Technology Holdings, Inc.'s return on equity (ROE) is 45.60%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Legacy Technology Holdings, Inc.'s market cap?

Legacy Technology Holdings, Inc. has a market capitalization of $1720.

OTC · Drug Manufacturers - Specialty & Generic

Legacy Technology Holdings, Inc. (LTHO) Stock

$0.00 OTC: LTHO Healthcare

Valuation

Metric	Value
Price	$0.00
Market Cap	$1720
P/E Ratio	-0.18
P/B Ratio	0.30
P/S Ratio	0.00
EPS (TTM)	$0.00
52-Week High	$0.06
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	45.60%
ROA	-279.28%
ROCE	34.52%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	0.00

Annual Financials (USD)

Metric	2019	2020
Revenue	$0	$0
Operating Profit	$0	$0
Net Profit	$0	$0
EPS	$0.00	$0.00
Op Margin	—	—

Balance Sheet (USD)

Metric	2019	2020
Total Assets	$0	$0
Total Liabilities	$0	$0
Cash	$0	$0
Borrowings	$0	$0

Cash Flow (USD)

Metric	2019	2020
Operating Cash Flow	—	$0
Investing Cash Flow	—	$0
Financing Cash Flow	—	$0
Net Cash Flow	—	$0
Free Cash Flow	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.51
FCF Yield	-1451.45%
Quick Ratio	0.00
Interest Coverage	-4.49
Return 1Y	0.00%
Return 3Y	-99.50%
Return 5Y	-98.36%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AREVFAREV Life Sciences Global Corp	$0.00	—	-1.87	$15881	0.00%
CNNXFCannAmerica Brands Corp.	$0.00	—	0.00	$704	0.00%
CSTFCuraScientific Corp	$0.00	—	0.00	$377345	0.00%
GBHPFGlobal Hemp Group Inc.	$0.00	—	-0.13	$2429	0.00%
GRVEGroove Botanicals, Inc.	$0.00	—	-0.66	$238572	0.00%

About Legacy Technology Holdings, Inc.

Legacy Technology Holdings, Inc., founded in 2012 and headquartered in Arvada, Colorado, specializes in creating and bringing to market an internet-based software solution. This platform is designed for both preventative genomic medicine and broader medical applications. It employs sophisticated algorithms to conduct thorough analyses of diverse individual patient data, encompassing lifestyle elements such as blood test results, biometric information, dietary habits, and environmental factors, in addition to nutraceutical, pharmaceutical, and genetic indicators.

Legacy Technology Holdings, Inc. (LTHO) stock trades at $0.00 with a market capitalization of $1720. The stock is valued at a price-to-earnings (P/E) ratio of -0.18, price-to-book of 0.30, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.06, and currently trades 100.0% below its 52-week high.

On profitability, Legacy Technology Holdings, Inc. generates a return on equity (ROE) of 45.60% — well above the market average, a sign of a high-quality business, return on capital employed of 34.52%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.genomics-giws.com